Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Tango Therapeutics Inc.
Sponsor

Tango Therapeutics Inc.

United States 201 Brookline Avenue Suite 901, 02215-4159, United States

About the sponsor

Clinical research is centered on locally advanced and metastatic solid tumors with MTAP deletion, including a broad range of advanced malignancies.

  • Metastatic MTAP-deleted solid tumors
  • Advanced solid tumor oncology
  • Anti-neoplastic activity

The sponsor’s oncology portfolio includes tumor types with high unmet need in advanced disease settings.

About Specializations

Tango Therapeutics Inc. runs clinical trials in conditions such as Neoplasm, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Safety and Effects of TNG908 in Patients with Advanced or Metastatic Solid Tumors Missing the MTAP Gene

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dobutamine Hydrochloride
  • Sponsor:Tango Therapeutics Inc.

Neoplasm

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam
  • Sponsor:Tango Therapeutics Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.